Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets…
- Recall date
- November 19, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0134-2025
- FDA classification
- Class II
- Brand / firm
- Mylan Institutional, Inc.
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
Subpotent and Superpotent Drug
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-041-20
Get recall alerts
Free email alert whenever Mylan Institutional, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Institutional, Inc.